Stancic Ana
SEC-identified person · CIK 1320271 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Immune Pharmaceuticals INC IMNPQ | Director | filed 2013 - 2015 |
| KV Pharmaceutical CO /DE/ kva/kvb | Director | filed 2010 - 2013 |
| Viskase Holdings, Inc. ENZND | Senior VP, Finance and CFO | filed 2011 - 2012 |
| Champions Sports INC csbr | Director | filed 2008 - 2011 |
| Omrix Biopharmaceuticals, Inc. OMRI | Chief Financial Officer | filed 2007 - 2007 |
| Imclone Systems INC/DE IMCL | VP, FINANCE & CAO | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.